Checkmate awaiting strategy: unlocking the potential of chimeric antigen receptor T-cell therapy in uveal melanoma

Saved in:
Bibliographic Details
Main Authors: Ahmed H. Al Sharie, Samah O. Al-Omari, Abdelwahab Aleshawi, Rami Al-Dwairi, Osama Al Deyabat
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1555842/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850087170140798976
author Ahmed H. Al Sharie
Samah O. Al-Omari
Abdelwahab Aleshawi
Rami Al-Dwairi
Osama Al Deyabat
Osama Al Deyabat
author_facet Ahmed H. Al Sharie
Samah O. Al-Omari
Abdelwahab Aleshawi
Rami Al-Dwairi
Osama Al Deyabat
Osama Al Deyabat
author_sort Ahmed H. Al Sharie
collection DOAJ
format Article
id doaj-art-c8f40ccc0233445c91c1f4354a08b345
institution DOAJ
issn 2234-943X
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-c8f40ccc0233445c91c1f4354a08b3452025-08-20T02:43:16ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-02-011510.3389/fonc.2025.15558421555842Checkmate awaiting strategy: unlocking the potential of chimeric antigen receptor T-cell therapy in uveal melanomaAhmed H. Al Sharie0Samah O. Al-Omari1Abdelwahab Aleshawi2Rami Al-Dwairi3Osama Al Deyabat4Osama Al Deyabat5Department of Pathology and Microbiology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, JordanDepartment of Internal Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, JordanDivision of Ophthalmology, Department of Special Surgery, Faculty of Medicine, Jordan University of Science and Technology, Irbid, JordanDivision of Ophthalmology, Department of Special Surgery, Faculty of Medicine, Jordan University of Science and Technology, Irbid, JordanUniversity of Illinois, Peoria, IL, United StatesThe Hashemite University, Zarqa, Jordanhttps://www.frontiersin.org/articles/10.3389/fonc.2025.1555842/fulluveal melanomachimeric antigen receptor t cells therapyCAR-Tpreclinical studiesclinical trialsand immunotherapy
spellingShingle Ahmed H. Al Sharie
Samah O. Al-Omari
Abdelwahab Aleshawi
Rami Al-Dwairi
Osama Al Deyabat
Osama Al Deyabat
Checkmate awaiting strategy: unlocking the potential of chimeric antigen receptor T-cell therapy in uveal melanoma
Frontiers in Oncology
uveal melanoma
chimeric antigen receptor t cells therapy
CAR-T
preclinical studies
clinical trials
and immunotherapy
title Checkmate awaiting strategy: unlocking the potential of chimeric antigen receptor T-cell therapy in uveal melanoma
title_full Checkmate awaiting strategy: unlocking the potential of chimeric antigen receptor T-cell therapy in uveal melanoma
title_fullStr Checkmate awaiting strategy: unlocking the potential of chimeric antigen receptor T-cell therapy in uveal melanoma
title_full_unstemmed Checkmate awaiting strategy: unlocking the potential of chimeric antigen receptor T-cell therapy in uveal melanoma
title_short Checkmate awaiting strategy: unlocking the potential of chimeric antigen receptor T-cell therapy in uveal melanoma
title_sort checkmate awaiting strategy unlocking the potential of chimeric antigen receptor t cell therapy in uveal melanoma
topic uveal melanoma
chimeric antigen receptor t cells therapy
CAR-T
preclinical studies
clinical trials
and immunotherapy
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1555842/full
work_keys_str_mv AT ahmedhalsharie checkmateawaitingstrategyunlockingthepotentialofchimericantigenreceptortcelltherapyinuvealmelanoma
AT samahoalomari checkmateawaitingstrategyunlockingthepotentialofchimericantigenreceptortcelltherapyinuvealmelanoma
AT abdelwahabaleshawi checkmateawaitingstrategyunlockingthepotentialofchimericantigenreceptortcelltherapyinuvealmelanoma
AT ramialdwairi checkmateawaitingstrategyunlockingthepotentialofchimericantigenreceptortcelltherapyinuvealmelanoma
AT osamaaldeyabat checkmateawaitingstrategyunlockingthepotentialofchimericantigenreceptortcelltherapyinuvealmelanoma
AT osamaaldeyabat checkmateawaitingstrategyunlockingthepotentialofchimericantigenreceptortcelltherapyinuvealmelanoma